Developing a new HIV vaccine using nanoparticles
Official title: cGMP Manufacture, Fill-Finish, Release, and Stability Testing of a Nanoparticle Based HIV Envelope Containing Vaccine
Funded at Advanced Bioscience Laboratories, INC. · NIH-11099643 · Data updated 2026-11-12
This study is working on a new HIV vaccine that uses tiny particles to help deliver important proteins, and it's designed to improve how we prevent HIV, so it could be a great option for people looking for safer and more effective protection.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Advanced Bioscience Laboratories, INC. NIH-funded |
| Lab location | 1 site (Kensington, United States) |
| Project start | August 29, 2021 |
| Project end | June 30, 2027 |
| Funding year | 2024 |
| Award (this year) | $479,043 |
| NIH project number | 272201700010I-P00005-759302100002-1 |
| Project ID | NIH-11099643 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for participation or benefit from this research would include individuals at high risk for HIV infection or those interested in HIV prevention.
✕Less likely to help
Patients who are already living with HIV or those who are not at risk for HIV infection may not receive direct benefits from this research.
What this research studies
This research focuses on creating and testing a new type of HIV vaccine that uses nanoparticles to deliver the HIV envelope protein. The project involves various stages, including manufacturing the vaccine, conducting preclinical tests, and preparing necessary regulatory documents for human clinical trials. Patients may benefit from this innovative approach as it aims to enhance the effectiveness and safety of HIV prevention strategies. The research will also ensure that the vaccine production follows strict quality control measures.
Why it matters
Potential benefit: If successful, this research could lead to a more effective and safer vaccine for preventing HIV infection.
How similar studies have gone: Other research has shown promise in developing nanoparticle-based vaccines for various diseases, indicating potential success for this approach in HIV vaccine development.
Where this research is happening
-
Advanced Bioscience Laboratories, INC.
Kensington, United States Active
Researchers
- Principal investigator: Fouts, Timothy — Advanced Bioscience Laboratories, INC.
- Study coordinator: Fouts, Timothy
Related research
Other NIH-funded projects on the same topics.
-
Development of vaccines and biologics for infectious diseases
This study is working on creating new vaccines to help protect people from infectious diseases, and it aims to make sure these vaccines are safe and effective before they are approved for use.
-
Developing new vaccines and biologics for infectious diseases
This study is all about creating and improving vaccines to help protect people from tough infections, including those that are hard to treat and could be used in bioterrorism, so that patients can have better options for staying healthy.
-
Developing a vaccine to fight fungal infections
This study is working on a new vaccine to help protect people, especially those with weakened immune systems, from serious fungal infections like Candida auris and Cryptococcus neoformans, which can be tough to treat.
-
Identifying and testing a new antibody treatment for Duchenne Muscular Dystrophy.
This study is looking at a new treatment for Duchenne Muscular Dystrophy (DMD) using a special type of antibody, and it aims to make sure the drug is safe and works well before it can be tested in people like you.
-
Developing and testing new oligonucleotides for medical use
This study is working on creating new types of medicines that target specific genes, which could lead to better treatments for patients with various health conditions.
-
Manufacturing a new treatment for pain management
This study is exploring a new way to help manage pain using a special compound called VHCA8*, and it's designed for people looking for better pain relief options that are safe and backed by science.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.